PERSPECTA

News from every angle

← Back to headlines

Lantern Pharma reports GAAP EPS of -$0.30

Lantern Pharma announced its GAAP EPS of -$0.30.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

seeking-alphaind1h ago

Lantern Pharma GAAP EPS of -$0.30

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Energy chief probes outages in PH grids

just now

Benue State Increases Internally Generated Revenue

8m ago

Trump's China Visit Amid US-Iran Tensions and Global Economic Shifts

13m ago